Total Non-Current Liabilities

$4.49B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$4.49Bperiod endingJun 30, 2026

REGN Quarterly Total Non-Current Liabilities ($11.40M → $4.49B)

Quarterly total non-current liabilities

High-resolution chart · PNG

REGN total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jun 30, 2001	10,075,000
Mar 31, 2001	10,919,000
Dec 31, 2000	12,358,000
Sep 30, 2000	12,605,000
Jun 30, 2000	13,119,000
Mar 31, 2000	13,989,000
Dec 31, 1999	14,200,000
Sep 30, 1999	15,000,000
Jun 30, 1999	15,700,000
Mar 31, 1999	16,000,000
Dec 31, 1998	16,300,000
Sep 30, 1998	15,900,000
Jun 30, 1998	18,800,000
Mar 31, 1998	18,500,000
Dec 31, 1997	18,800,000
Sep 30, 1997	18,700,000
Jun 30, 1997	19,300,000
Mar 31, 1997	18,400,000
Dec 31, 1996	18,700,000
Sep 30, 1996	17,500,000
Jun 30, 1996	16,900,000
Mar 31, 1996	13,600,000
Dec 31, 1995	13,000,000
Sep 30, 1995	7,100,000
Jun 30, 1995	7,800,000
Mar 31, 1995	8,600,000
Dec 31, 1994	9,200,000
Sep 30, 1994	8,100,000
Jun 30, 1994	7,400,000
Mar 31, 1994	8,300,000
Dec 31, 1993	6,100,000
Sep 30, 1993	6,400,000
Jun 30, 1993	6,600,000
Mar 31, 1993	6,600,000
Dec 31, 1992	6,100,000
Sep 30, 1992	5,600,000
Jun 30, 1992	5,200,000
Mar 31, 1992	5,200,000
Dec 31, 1991	4,500,000
Sep 30, 1991	3,500,000
Jun 30, 1991	3,900,000
Dec 31, 1990	11,400,000